Ohio activists submitted revised ballot language for the proposed adult-use legalization measure they want to place on the 2022 ballot after the state attorney general , David Yost, deemed the initial draft summary to be misleading.
The state’s Board of Pharmacy approved the licensing of 73 new dispensaries bringing the total to 130 across the state. The initial 38 cultivation licenses issued are limited to 25K sq.ft. and have not yet has been approved for expansion. Regulators recently added chronic pain, Huntington's disease, terminal illness and spasticity to the list of qualifying conditions, which will result in a significant increase in medical-card holding patients.
July 2021 | Columbia Care acquires four dispensaries from CannAscend for $14.2MM
March 2021 | AYR Strategies acquires cultivator Parma Wellness Center LLC in a $17MM cash deal
October 2020 | GTI announces a manufacturing sale-leaseback for $32.2MM with IIPR
July 2020 | Verdant Creations sells four of its five dispensaries to Cresco Labs
With the one-year waiting period expiring and program expansion underway, there has been a flurry of buying activity in the Buckeye State. Further investment is needed to build cultivation and retail, as sales dollars freely flow across the border to Michigan, where both the product and taxes are less expensive.
With only 12 Level I cultivators operational and 73 new dispensaries to be issued, the market has plenty of room for more players. Existing license holders should solidify their market positions and hold on for a fun ride.
Investors have ample opportunity to invest in attractive ROI projects over the next several years as the medical market expands and ultimately transitions to adult-use.
*Cultivators are licensed as either Level I, limited to 25K sq.ft., and expansions up to 50K sq.ft. or Level II, limited to 3K sq.ft. with expansions up to 6K sq.ft. The department can then approve Level I and II growers for up to 75K sq.ft. and 9K sq.ft. of expansion, respectively.